CrossrefInfokarte
A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3
Rheumatology International · 2020-07 · 40 (7) · 1081-1087
DOI: 10.1007/s00296-020-04517-4 ↗Abstract
Kein Abstract verfügbar.
EUVIMED